| 0.0111 0.009 (362.5%) | 12-04 14:41 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Youngevity International, Inc. functions as a global enterprise, specializing in the development and distribution of health and nutritional products alongside related services. The company's business activities are organized into three principal divisions: Direct Selling, Commercial Coffee, and Commercial Hemp. Within its comprehensive direct selling framework, Youngevity presents an extensive assortment of goods. These include dietary supplements, premium coffee blends, weight management solutions, skincare and cosmetic items, general health and wellness products, various packaged foods, lifestyle accessories, pet care essentials, and digital offerings. Furthermore, the company extends its services to telecare health, apparel, fashion accessories, and business lending solutions. In the Commercial Coffee sector, Youngevity is responsible for producing and marketing several distinct coffee brands, such as Café La Rica, Café Alma, Josie's Java House, Javalution Urban Grind, Javalution Daily Grind, and Javalution Royal Roast. It also sells its JavaFit brand directly to consumers. Beyond individual sales, the company supplies coffee and associated equipment to entities like wellness and retirement communities, cruise lines, and coffee service providers, leveraging both direct sales and a broad distribution network. The Commercial Hemp division focuses specifically on providing CBD oils derived from hemp. To reach its customer base, Youngevity International utilizes a range of dedicated consumer websites for product promotion, including youngevity.com, ygyi.com, heritagemakers.com, hempfx.com, clrroasters.com, cafelarica.com, and javalution.com. The company, founded in 1996 and headquartered in Chula Vista, California, operated under the name AL International, Inc. until July 2013, when it officially adopted its current designation as Youngevity International, Inc.
Wed, 21 Sep 2022
Youngevity International, Inc Granted Motion for Summary Judgement Against Former President Dwayne Dundore - PR Newswire
Thu, 14 Jan 2021
Youngevity International, Inc. Provides Business Update in Open Letter to Shareholders - PR Newswire
Mon, 25 Feb 2019
Youngevity Completes Acquisition of Assets of Khrysos Global - Direct Selling News
Mon, 14 Jan 2019
Youngevity International partners with Icelandic Glacial - proactiveinvestors.co.uk
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
OTC
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|